UBS O'Connor’s Kindred Biosciences KIN Stock Holding History
Bought
Maintained
Sold
Other funds holding KIN
UBS O'Connor's KIN Position: Q3 2018 in Review
UBS O'Connor sold out of Kindred Biosciences (KIN) in Q3 2018, closing a stake of 100,000 shares — an estimated $1.06M sold.
UBS O'Connor first reported a position in KIN in Q3 2014 and held it in 2 quarters. The position peaked at $1.06M in Q2 2018. 81 funds tracked by Wall St. Rank hold KIN as of Q3 2018.
- UBS O'Connor reported no remaining Kindred Biosciences position as of Q3 2018 after selling out during the quarter.
- UBS O'Connor sold 100,000 Kindred Biosciences shares in Q3 2018, an estimated $1.06M.
- UBS O'Connor first reported a position in Kindred Biosciences in Q3 2014 and held it in 2 quarters.
- UBS O'Connor's Kindred Biosciences position peaked at $1.06M in Q2 2018.
- 81 funds tracked by Wall St. Rank held Kindred Biosciences as of Q3 2018.
Based on UBS O'Connor's 13F filing for Q3 2018, filed 14 Nov 2018.